Cantargia publishes full year report for 2020
Cantargia AB’s (”Cantargia”) full year report for 2020 is now available on the company’s web page www.cantargia.com/en/investors/financial-reports.Significant events in the fourth quarter · The first patient started treatment in the US phase 1 study evaluating combination therapy with CAN04 and pembrolizumab. · The recruitment of patients with pancreatic cancer for the CANFOUR phase 2a study was completed and positive interim results were presented. · At an extraordinary general meeting in October, Flavia Borellini was elected as a new Director of the company. · In December,